EARNEST Partners’s Amgen AMGN Stock Holding History

EARNEST Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-280	Closed	-$75.3K	–	330
2023 Q3	$75.3K	Hold	280	–	–	﹤0.01%	335
2023 Q2	$62.2K	Hold	280	–	–	﹤0.01%	335
2023 Q1	$67.7K	Hold	280	–	–	﹤0.01%	325
2022 Q4	$73.5K	Hold	280	–	–	﹤0.01%	319
2022 Q3	$63K	Hold	280	–	–	﹤0.01%	312
2022 Q2	$68K	Hold	280	–	–	﹤0.01%	313
2022 Q1	$68K	Hold	280	–	–	﹤0.01%	318
2021 Q4	$63K	Hold	280	–	–	﹤0.01%	322
2021 Q3	$60K	Hold	280	–	–	﹤0.01%	321
2021 Q2	$68K	Hold	280	–	–	﹤0.01%	316
2021 Q1	$70K	Hold	280	–	–	﹤0.01%	307
2020 Q4	$64K	Hold	280	–	–	﹤0.01%	304
2020 Q3	$71K	Hold	280	–	–	﹤0.01%	282
2020 Q2	$66K	Hold	280	–	–	﹤0.01%	285
2020 Q1	$57K	Hold	280	–	–	﹤0.01%	285
2019 Q4	$67K	Sell	280 -26	-8%	-$5.73K	﹤0.01%	290
2019 Q3	$59K	Hold	306	–	–	﹤0.01%	297
2019 Q2	$56K	Hold	306	–	–	﹤0.01%	306
2019 Q1	$58K	Hold	306	–	–	﹤0.01%	297
2018 Q4	$60K	Hold	306	–	–	﹤0.01%	285
2018 Q3	$63K	Hold	306	–	–	﹤0.01%	292
2018 Q2	$56K	Sell	306 -51	-14%	-$9.02K	﹤0.01%	297
2018 Q1	$61K	Hold	357	–	–	﹤0.01%	290
2017 Q4	$62K	Buy	+357	New	+$63.2K	﹤0.01%	283
2017 Q1	–	Sell	-357	Closed	-$52K	–	271
2016 Q4	$52K	Buy	+357	New	+$53.7K	﹤0.01%	279

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EARNEST Partners's AMGN Position: Q4 2023 in Review

EARNEST Partners sold out of Amgen (AMGN) in Q4 2023, closing a stake of 280 shares — an estimated $75.3K sold.

EARNEST Partners first reported a position in AMGN in Q4 2016 and held it in 25 quarters. The position peaked at $75.3K in Q3 2023. 2,717 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

EARNEST Partners reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 280 Amgen shares in Q4 2023, an estimated $75.3K.
EARNEST Partners first reported a position in Amgen in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Amgen position peaked at $75.3K in Q3 2023.
2,717 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.